| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/18/2006 | CN1723012A Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721416A Substituted methylene pyrones derivatives and their preparing process and use |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721409A Dibenzo(b,f)azepine derivatives |
| 01/18/2006 | CN1721408A 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof |
| 01/18/2006 | CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 01/18/2006 | CN1721403A Water soluble bilirubin and its synthesis process and use |
| 01/18/2006 | CN1720993A Stem cell preparation for treating Alzheimer disease and its preparation process |
| 01/18/2006 | CN1720975A Asari dripping pills and its preparation process |
| 01/18/2006 | CN1720954A Method for utilizing fermentative soybean liquid extract |
| 01/18/2006 | CN1720949A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 01/18/2006 | CN1720947A Dripping pills with mistletoe and Chinese angelica root and process for preparing the same |
| 01/18/2006 | CN1720916A Rapidly decomposing administrable form for releasing active ingredient in oral cavity or bodily cavity |
| 01/18/2006 | CN1720905A Application of beta-Asarone in pharmacy |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1236813C Self-emulsifying compositions for drugs poorly soluble in water |
| 01/18/2006 | CN1236812C Chinese medicine for abstaining toxin drug and its preparation process |
| 01/18/2006 | CN1236793C Medicinal formula for treating sciatic nerve disease and protrusion of lumbar intervertebral disc |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236774C Highly concentrated stable meloxicam solutions |
| 01/18/2006 | CN1236773C Preparation for analgesia and anesthesia or treating drug dependence |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/18/2006 | CN1236759C New pharmaceutical preparation for pain management |
| 01/18/2006 | CN1236699C Healthy food |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987176 Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987119 Pharmaceutically acceptable salts thereof; their use as inhibitors of Raf kinases and pharmaceutical compositions containing them and anticancer agents |
| 01/17/2006 | US6987117 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987014 Isolated nucleic acid molecules encoding human drug metabolizing proteins |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6986984 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |
| 01/17/2006 | CA2152284C Condensed benzo(d)isoxazole derivatives and their use as psychoactive agents |
| 01/17/2006 | CA2131495C Double-layered oxcarbazepine tablets |
| 01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
| 01/15/2006 | CA2478742A1 A system and method for addiction cessation |
| 01/12/2006 | WO2006004294A1 Extract of nelumbinis semen for the treatment of depresssion, medicinal composite an dhealth foods including the extract of nelumbinis semen |
| 01/12/2006 | WO2006004194A1 METHOD OF SCREENING REMEDY FOR ALZHEIMER’S DISEASE TARGETING TGF β2 |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/12/2006 | WO2004089951A8 Imidazopyridine derivatives having an affinity for melanocortin receptors |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009512 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009465 Treatment of sleep disorders using sleep target modulators |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009452 Therapeutic targeting of PARC/CCL18 and its signaling in pulmonary fibrosis |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009405 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060008900 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 01/12/2006 | US20060008842 Method of measuring neprilysin activity |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | DE102004030987A1 Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene-hydrazide |
| 01/12/2006 | DE102004030305A1 Preventing or treating neurodegenerative or dementia diseases characterized by molecular pathology of microtubuli-associated tau protein comprises administering a K252a derivative |
| 01/12/2006 | DE102004030099A1 Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines as serotonin and / or norepinephrine reuptake inhibitor and / or μ-opioid receptor modulators |
| 01/12/2006 | DE102004028940A1 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält Orally disintegrating pharmaceutical composition containing risperidone |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572685A1 Substituted 1-propiolylpiperazines compounds |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/12/2006 | CA2572119A1 Combination therapies utilizing benzamide inhibitors of the p2x7 receptor |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2570185A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/12/2006 | CA2569826A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2569589A1 Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/12/2006 | CA2568835A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2565683A1 Substituted azepine derivatives as serotonin receptor modulators |
| 01/11/2006 | EP1615032A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |